The IFPA Forum 2025 will unite stakeholders from across the Americas to address the urgent challenges faced by individuals ...

Dry skin, itching, and fiery eczema can be caused by allergens, stress, or an overactive immune response.Steroid creams ...

Celltrion today announced the U.S. launch of STEQEYMA��(ustekinumab-stba), a biosimilar to STELARA� (ustekinumab), following approval by the U.S. Food and Drug Administration (FDA) in December 2024.

STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as ...

Icotrokinra met all primary endpoints in the studies, demonstrating significant skin clearance and clinical remission.

ORLANDO — Nutrition plays a role in the management of atopic dermatitis, according to research presented at the American Academy of Dermatology Annual Meeting.“Conventional medicine, including ...

Arcutis is a rare topical dermatology player with accelerating launch metrics and continued growth. Read more about the ...

Some patients with psoriasis may have a super response to guselkumab, but questions remain regarding the generalizability of treatment strategies.

Higher rates of venous thromboembolism, lymphoma, and infections were observed in those with atopic dermatitis and psoriasis vs control patients.

Growing up, I watched my mom apply fun lipsticks, powder her face in small compact mirrors, and make sure her lashes were ...

Adults and adolescents treated with icotrokinra experienced improvements in their moderate to severe plaque psoriasis, ...